A pilot study of the pharmacokinetics, efficacy, and acceptability of a novel nicotine inhaler in smokers
Phase 1
Recruiting
- Conditions
- Tobacco use disorderNicotine addictionMental Health - Addiction
- Registration Number
- ACTRN12606000423516
- Lead Sponsor
- Professor Julian Crane
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Smoked >10 cigarettes per day.
Exclusion Criteria
Recent use of other nicotine replacement therapy such as bupropion; cardiovascular, psychiatric history of note.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics of nicotine[At time = 0, 1, 5, 10, 15, 30 minutes]
- Secondary Outcome Measures
Name Time Method Acceptability, Cigarette Evaluation Scale, Questionnaire of Smoking Urges.[Assessed immediately after administration.]